Jupiter Neurosciences and Catalent Partner to produce JOTROL softgel capsules

Jupiter Neurosciences Inc., a pharmaceutical company in the clinical stage, is developing JOTROL, a patented platform based on resveratrol, and has reached an agreement with Catalent Pharma Solutions LLC to produce JOTROL softgel capsules to...

Vanda Pharma & AnaptysBio Partner to Advance Imsidolimab for GPP Treatment

Vanda Pharmaceuticals Inc. and AnaptysBio, Inc. announced an exclusive worldwide licensing agreement for the development and marketing of imsidolimab (IL-36R antagonist mAb), which has successfully finished two registration-supporting global Phase...

Sudarshan Pharma Secures 188 Cr via 4.3 Cr Convertible Warrants

Sudarshan Pharma Industries revealed the authorization of Rs 188 Cr in capital raising via 4.3 Cr convertible warrants. The firm acknowledged the contract established between the Monitoring agency and the enterprise on January 29, 2025, and...

Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore

The Union Budget 2025 has proposed a 9.78 per cent rise in funding for healthcare for the fiscal year 2025-26, amounting to Rs. 99,858.56 crore in contrast to Rs. The ministry of health and family welfare states that the amount will be 90,958.63...

Pharma Quality Excellence Awards 2025

After a successful edition of the maiden award ceremony in 2024, Eminence is thrilled to announce the Pharma Quality Excellence Awards 2025, taking place on April 25th, 2025, in conjunction with the 5th Annual Pharma GMP and Quality Management 2025

5th Annual Pharma GMP and Quality Management 2025

The pharmaceutical industry is undergoing rapid transformation, with an increasing focus on quality, compliance, and innovation in manufacturing processes. In this context, Eminence Business Media has announced 5th Annual Pharma GMP and Quality Manag

Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation

Bajaj Healthcare announced that it has obtained approval from the Drug Controller General of India (DCGI) to produce both the API and drug formulation of Pimavanserin. Pimavanserin is an atypical antipsychotic utilized to treat hallucinations and...

Lupin and Avas Launch NaMuscla in Italy for NDM Disorder Relief

Global pharmaceutical giant Lupin Limited (Lupin) and Avas Pharmaceuticals SRL (Avas), a prominent pharmaceutical firm recognized for its proficiency in marketing branded drugs, declared the introduction of Lupin’s orphan medication NaMuscla...

ColdVentures, Medco Partner to Launch ColdVest for Heat Stroke Prevention

ColdVentures, a top medical device firm dedicated to fighting heat-related fatalities, has revealed a distribution deal with Medco Sports Medicine (Medco), the country's leading source of sports medicine supplies and equipment. This partnership...

SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety

SCHOTT Pharma, a leader in drug containment and delivery solutions, introduces the next generation of SCHOTT TOPPAC infuse polymer syringes, a system aimed at enhancing safety, efficiency, and sustainability in the healthcare sector. Created in...

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring